Clinical characteristics of COVID-19 patients who underwent tracheostomy and its effect on outcome : A retrospective observational study

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved..

BACKGROUND: The exponential rise in Coronavirus disease 2019 (COVID-19) cases has resulted in an increased number of patients requiring prolonged ventilatory support and subsequent tracheostomy. With the limited availability of literature regarding the outcomes of COVID-19 patients with tracheostomy, we attempted to study the clinical characteristics and multiple parameters affecting the outcomes in these patients.

AIM: To determine all-cause mortality following tracheostomy and its association with various risk factors in COVID-19 patients.

METHODS: This retrospective study included 73 adult COVID-19 patients admitted to the ICU between 1 April, 2020 and 30 September, 2021 who underwent tracheostomy as a result of acute respiratory failure due to COVID-19. The data collected included demographics (age, sex), comorbidities, type of oxygen support at admission, severity of COVID-19, complications, and other parameters such as admission to tracheostomy, intubation to tracheostomy, ICU stay, hospital stay, and outcome.

RESULTS: This study included 73 adult patients with an average age of 52 ± 16.67 years, of which 52% were men. The average time for admission to tracheostomy was 18.12 ± 12.98 days while intubation to tracheostomy was 11.97 ± 9 days. The mortality rate was 71.2% and 28.8% of patients were discharged alive. The mean duration of ICU and hospital stay was 25 ± 11 days and 28.21 ± 11.60 days, respectively. Greater age, severe COVID-19, mechanical ventilation, shock and acute kidney injury were associated with poor prognosis; however, early tracheostomy in intubated patients resulted in better outcomes.

CONCLUSION: Patients with severe COVID-19 requiring mechanical ventilation have a poor prognosis but patients with early tracheostomy may benefit with no added risk. We recommend that the timing of tracheostomy be decided on a case-by-case basis and a well-designed randomised controlled trial should be performed to elucidate the potential benefit of early tracheostomy in such patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

World journal of virology - 11(2022), 6 vom: 25. Nov., Seite 477-484

Sprache:

Englisch

Beteiligte Personen:

Singh, Yudhyavir [VerfasserIn]
Soni, Kapil Dev [VerfasserIn]
Singh, Abhishek [VerfasserIn]
Choudhary, Nikita [VerfasserIn]
Perveen, Fahina [VerfasserIn]
Aggarwal, Richa [VerfasserIn]
Patel, Nishant [VerfasserIn]
Kumar, Shailendra [VerfasserIn]
Trikha, Anjan [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
ICU
Intubation
Journal Article
Mechanical ventilation
Oxygen therapy
Tracheostomy

Anmerkungen:

Date Revised 10.12.2022

published: Print

Citation Status PubMed-not-MEDLINE

doi:

10.5501/wjv.v11.i6.477

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM349954194